Physician
Pulmonary & Sleep of Tampa Bay PL
Pulmonary & Sleep of Tampa Bay PL was paid $3.07M by Medicaid between Jan 2018 and Nov 2024, across 29 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoPULMONARY & SLEEP OF TAMPA BAY PL
BRANDON, FL 33511
BRANDON, FL 33511
33aNPI1821398538assigned 10/27/2010
33bProvider typeSleep Medicine (Internal Medicine) Physician
28Total paid$3.07M
24GClaims97,529
24DCodes billed29
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Sleep Medicine (Internal Medicine) Physician providers in Florida
Rank by total paid#1 of 22
Median peer was paid$20K
This provider vs. median157×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,198 | $9K | |
| 2019 | 11,519 | $383K | |
| 2020 | 11,043 | $494K | |
| 2021 | 12,437 | $499K | |
| 2022 | 18,562 | $718K | |
| 2023 | 27,114 | $712K | |
| 2024incomplete | 14,656 | $251K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 29,745 | 25,082 | $978K |
| 95811 | 15% | 1,379 | 1,241 | $454K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 11% | 1,021 | 936 | $348K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 11% | 3,832 | 3,492 | $335K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 9.7% | 1,918 | 1,695 | $296K |
| 94618 | 9.4% | 5,121 | 4,623 | $288K | |
| 94010 | 3.3% | 17,078 | 15,073 | $101K | |
| 99443 | 2.1% | 3,411 | 2,548 | $65K | |
| 94729 | 2.0% | 5,826 | 5,214 | $60K | |
| 94726 | 1.8% | 5,619 | 5,026 | $55K | |
| 94060 | 1.7% | 3,178 | 2,923 | $51K | |
| 94664 | <1% | 5,377 | 4,769 | $12K |
17 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 460 | $8K |
| 96401 | <1% | 89 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 73 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 227 | $1K |
| 99406 | <1% | 299 | $1K | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 8,445 | $709.32 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 2,011 | $400.64 |
| 94727 | <1% | 27 | $202.08 | |
| 99457 | <1% | 54 | $71.78 | |
| 99458 | <1% | 48 | $44.69 | |
| 99454 | <1% | 15 | $40.76 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 818 | $0.00 |
| 1036F | 0% | 279 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 936 | $0.00 |
| G9991 | Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period | 0% | 70 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 160 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZANCHI, DRAGOS (PRESIDENT)